Vaccines for kids ages 2 to 5 may be on the way. Here's what we know so far.
Go Deeper.
Create an account or log in to save stories.
Like this?
Thanks for liking this story! We have added it to a list of your favorite stories.
Pfizer is submitting data to the FDA on a COVID-19 vaccine for children ages 2 to 5. This is generally the first step in requesting emergency use authorization from the FDA for a new vaccine.
It’s very early stages, but we wanted to give you an idea of what this all means and what families might be able to expect in the next weeks and months of the pandemic. Joe Kurland, specialist in vaccines at Children’s Minnesota, broke down the research and the process for host Cathy Wurzer.
Use the audio player above to listen to the full conversation.
Subscribe to the Minnesota Now podcast on Apple Podcasts, Google Podcasts, Spotify or wherever you get your podcasts.
Turn Up Your Support
MPR News helps you turn down the noise and build shared understanding. Turn up your support for this public resource and keep trusted journalism accessible to all.